Gao Zeren

Title: The Innovations of Gao Zeren

Introduction

Gao Zeren is a notable inventor based in Redmond, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins that target inflammatory diseases. With a total of 2 patents, her work has the potential to impact therapeutic approaches for various conditions.

Latest Patents

Gao Zeren's latest patents include the development of soluble IL-17RA/RC fusion proteins and related methods. These patents disclose antagonists of IL-17A and IL-17F, which are based on soluble IL-17RA and IL-17RC fusion proteins. The hybrid soluble receptors comprise portions of both IL-17RC and IL-17RA, referred to as 'IL-17RC/IL-17RA'. These antagonists serve to block, inhibit, reduce, antagonize, or neutralize the activity of IL-17F, IL-17A, or both. Furthermore, the patents outline methods for using these antagonists to treat diseases, particularly inflammatory diseases mediated at least in part by IL-17A and/or IL-17F.

Career Highlights

Gao Zeren is currently employed at Zymogenetics, Inc., where she continues to innovate in the field of biotechnology. Her work focuses on developing therapeutic solutions that address significant health challenges.

Collaborations

Some of her notable coworkers include Steven D Levin and Mark W Rixon, who contribute to the collaborative environment at Zymogenetics, Inc.

Conclusion

Gao Zeren's contributions to the field of biotechnology through her innovative patents and work at Zymogenetics, Inc. highlight her role as a leading inventor in the development of treatments for inflammatory diseases. Her research continues to pave the way for advancements in medical therapies.